awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40656850-4C12EB1B-3576-4F13-A611-4B98A6C95F8F
Q40656850-4C12EB1B-3576-4F13-A611-4B98A6C95F8F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40656850-4C12EB1B-3576-4F13-A611-4B98A6C95F8F
First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study.
P2860
Q40656850-4C12EB1B-3576-4F13-A611-4B98A6C95F8F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40656850-4C12EB1B-3576-4F13-A611-4B98A6C95F8F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c76df63e6180c9a0345733d17bf74d4dbb33488f
P2860
Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.